The Journal of Clinical Endocrinology & Metabolism · 2016 · 27 citations · 8 references
MedicineEndocrinologyGynecologyAndrologyReproductive EndocrinologyReproductive MedicineGonadal EndocrinologyGonadal HormonesGonadal Steroid HormonesHormonal TherapyHypothalamic-pituitary-gonadal AxisInsulin ResistanceGnrh AgonistsGnrh AnaloguesGonadal Androgen ProductionGonadotropin-releasing Hormone Agonist TherapyHypothalamic-pituitary-gonadal Axis DysfunctionHypothalamic-pituitary-gonadal Axis RegulationHypothalamic-pituitary-ovarian Axis DysfunctionInsulin Resistance Syndrome
Context: Hyperinsulinemia can lead to pathologic ovarian growth and androgen production. Case Description: A 29-year-old woman developed an autoantibody to the insulin receptor (type B insulin resistance), causing extreme insulin resistance and hyperinsulinemia. Testosterone levels were elevated to the adult male range. Treatment with gonadotropin-releasing hormone (GnRH) analog led to normalization of testosterone, despite persistent extreme insulin resistance. Conclusions: This case demonstrates that gonadotropins are necessary for insulin to cause pathologic ovarian androgen production. Suppression of gonadotropins with GnRH analogs may be a useful therapeutic option in patients with severe hyperandrogenism or ovarian enlargement because of hyperinsulinemia.
8
Elif Arioǧlu, Alexa Andewelt, CRYSTAL DIABO et al. · Medicine · 2002 · 224 citations
Medicine, Endocrinology, Immunology +13
Jeffrey S. Flier, Robert S. Bar, Michele Muggeo et al. · The Journal of Clinical Endocrinology & Metabolism · 1978 · 119 citations